Titan Pharmaceuticals logo
Titan Pharmaceuticals TTNP
$ 3.35 2.45%

Quarterly report 2024-Q2
added 08-15-2024

report update icon

Titan Pharmaceuticals EBITDA per Share 2011-2024 | TTNP

Annual EBITDA per Share Titan Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-9.53 -14.9 -0.92 -2.16 -21.7 -19.8 -120 41 -57.5 -32.9 -9.45 -124 -175

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
41 -175 -42

Quarterly EBITDA per Share Titan Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- -1.24 - - - -2.2 - -0.17 -0.17 -0.23 - -0.18 -0.22 -0.28 - -0.3 -0.47 -0.69 - -238 -0.35 -0.32 - -442 -0.02 -0.11 - -0.18 -0.16 -0.16 - -0.11 0.6 -0.09 - -0.08 -0.05 -0.08 - -0.03 - -0.01 - - - - - -0.04 -0.03 -0.06 - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
0.6 -442 -22.2